# Pharmacokinetics of Zoledronic Acid in Patients on Dialysis

> **NCT07741136** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Campinas, Brazil** · enrollment: 24 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Osteoporosis
- Dialysis

## Interventions

- **DRUG:** Zoledronic Acid Injection, 5.0 mg, single dose
- **DRUG:** Zoledronic Acid Injection, 2.5 mg, single dose
- **DRUG:** Zoledronic Acid Injection, 5.0 mg, single dose

## Key facts

- **NCT ID:** NCT07741136
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2027-08-15
- **Final completion:** 2028-08-15
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741136, "Pharmacokinetics of Zoledronic Acid in Patients on Dialysis". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07741136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*